CRINETICS PHARM (CRNX) moved sharply on the prior session’s higher-than-average trading volume, but emerging trends in earnings estimate revisions may not provide enough near-term momentum to sustain further upside.
CRINETICS PHARM (CRNX) moved sharply on the prior session’s higher-than-average trading volume, but emerging trends in earnings estimate revisions may not provide enough near-term momentum to sustain further upside.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
